Joanna C Masters

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Locally Advanced

Small Cell Lung Cancer

Top Venues

Cancer research communications

Journal of clinical pharmacology

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study. Cancer research communications (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Kenneth Todd Moore, Peter N Zannikos, Joanna C Masters, Stefan Willmann, Jinshan Shen, Charles Frost
The Importance of Assessing Drug Pharmacokinetics and Pharmacodynamics in the Obese Population During Drug Development. Journal of clinical pharmacology (2023)
Dionna J Green, Joanna C Masters, null null
Pharmacological Arguments Against the Use of Ketamine in Nonmedical Settings. Journal of clinical pharmacology (2021)
Joanna C Masters, Elly Barry, Beverly Knight
Population Pharmacokinetics of Gemtuzumab Ozogamicin in Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia. Clinical pharmacokinetics 58 (2) (2020)
Joanna C Masters, Peter H Wiernik
Are We Ready to Include Organ-Impaired Patients in Oncology Trials? A Clinical Pharmacology Perspective on Recent Recommendations. Journal of clinical pharmacology 58 (6) (2018)